Keymed Biosciences Co.ltd
Clinical trials sponsored by Keymed Biosciences Co.ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New shot could tame stubborn hives that antihistamines Can't Results expected Nov 2026 (estimated)
- New injection aims to tame kidney disease Results expected Mar 2027 (estimated)
- First human test of CM583: can this biologic pass the safety check? Results expected Jul 2027 (estimated)
- New hope for Tough-to-Treat multiple myeloma: CM336 enters phase 3 trial Results expected Sep 2027 (estimated)